Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4596471 | 0.77 | ALDH1A1 (0.48) | ALDH1A1ALOX15HIF1AKMT2AHTT | |
| Ethane SCHEMBL28624063 | 0.76 | ALDH1A1 (0.47) | ALDH1A1ALOX15HIF1AKMT2AHTT | |
| SCHEMBL7086340 | 0.76 | HCAR2 (0.47) | ALDH1A1ALOX15HIF1AKMT2AHTT | |
| SCHEMBL7086342 | 0.76 | HCAR2 (0.47) | ALDH1A1ALOX15HIF1AKMT2AHTT | |
| SCHEMBL7087313 | 0.76 | HCAR2 (0.47) | ALDH1A1ALOX15HIF1AKMT2AHTT | |
| SCHEMBL2868880 | 0.75 | ALDH1A1 (0.46) | ALDH1A1ALOX15HIF1AKMT2AMEN1 | |
| SCHEMBL6552317 | 0.74 | ALDH1A1 (0.58) | ALDH1A1ALOX15HIF1AKMT2AMEN1 | |
| SCHEMBL8647287 | 0.74 | ALDH1A1 (0.58) | ALDH1A1ALOX15HIF1AKMT2AMEN1 | |
| SCHEMBL7099802 | 0.74 | ALDH1A1 (0.58) | ALDH1A1ALOX15HIF1AKMT2AMEN1 | |
| SCHEMBL25271578 | 0.74 | NPSR1 (0.73) | NPSR1ALDH1A1ALOX15HIF1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204038-A1 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | CARLONI SILVIA | 2010-08-12 | — | — | US | disclosed |
| EP-1765496-B1 | CATALYSTS BASED ON COPPER COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA SPA (IT) | 2010-07-14 | — | — | EP | disclosed |
| US-7723539-B2 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid | ENDURA S.P.A. (IT) | 2010-05-25 | — | — | US | disclosed |
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | ENDURA S.P.A. (IT) | 2008-01-24 | — | — | US | disclosed |
| EP-1765496-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.p.A. (IT) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005123254-A1 | CATALYSTS BASED ON METAL COMPLEXES FOR THE SYNTHESIS OF OPTICALLY ACTIVE CHRYSANTHEMIC ACID | ENDURA S.P.A. (IT) | 2005-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021237-A1 | Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid | SCO2, ME1, ME3 | NPSR1 4246/4885ALDH1A1 1925/4885ALOX15 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.